This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Go to /pro/cpd-dashboard page

This page is worth 0.05 CPD credits. CPD dashboard

Go to /account/subscription-details page

This page is worth 0.05 CPD credits. Upgrade to Pro

Gaucher's disease type 2

Authoring team

Gaucher's disease type 2 is the infantile form of the disease, with no predilection for Jews. There is virtually no glucerebrosidase activity in the tissues.

In this disease there is central nervous system dysfunction, convulsions, and progressive mental deterioration dominate, although organs such as the liver, spleen, and the lymph nodes are also affected.

Type 2

Phenotype

Accounts for 1% of GD cases.

Typically neonatal-infantile onset with a rapidly progressive fatal course.

The median age of death is 9 months

Visceral symptoms

Hepatomegaly, splenomegaly, hydrops fetalis (neonatal presentation) and interstitial lung disease

Hematopoietic symptoms

Anaemia and thrombocytopenia

Orthopaedic symptoms

Arthrogryposis in severe cases, and generally death before bony abnormality

Neurologic symptoms

Bulbar palsies, hypertonicity, abnormal ocular saccades and cognitive impairment

 


Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.